2 studies found for:    RENAL CANCER E7080
Show Display Options
RSS Create an RSS feed from your search for:
RENAL CANCER E7080
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment
Condition: Metastatic Renal Cell Carcinoma
Interventions: Drug: Lenvatinib;   Drug: Everolimus;   Drug: Lenvatinib plus Everolimus
2 Not yet recruiting Study of Lenvatinib in Combination With Everolimus in Patients With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)
Condition: Carcinoma, Renal Cell
Interventions: Drug: Lenvatinib;   Drug: Everolimus

Indicates status has not been verified in more than two years